Signup Crypto ETF Stocks News

NEUBERGER BERMAN HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION - Neuberger Berman High ( AMEX:NHS )

NEW YORK, May 30, 2025 /PRNewswire/ -- Neuberger Berman High Yield Strategies Fund Inc. ( NYSE:NHS ) ( the "Fund" ) has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on June 30, 2025, has a record date of June 16, 2025, and ...

Source: www.benzinga.com
May 30, 2025 | 20:30:00
Category: Markets

Rivalry Provides Update on Management Cease Trade Order

TORONTO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Rivalry Corp. ( the "Company" or "Rivalry" ) ( TSXV: RVLY ) ( OTCQX: RVLCF ) ( FSE: 9VK ) , is providing this bi-weekly update on the status of a management cease trade order granted on May 1, 2025 ( the "MCTO" ) by its principal regulator, the Ontario ...

Source: www.globenewswire.com
May 30, 2025 | 20:30:00
Category: News

NEUBERGER BERMAN NEXT GENERATION CONNECTIVITY FUND ANNOUNCES MONTHLY DISTRIBUTION - Neuberger Berman Next ( NYSE:NBXG )

NEW YORK, May 30, 2025 /PRNewswire/ -- Neuberger Berman Next Generation Connectivity Fund Inc. ( NYSE:NBXG ) ( the "Fund" ) has announced a distribution declaration of $0.10 per share of common stock.

Source: www.benzinga.com
May 30, 2025 | 20:30:00
Category: Markets

NEUBERGER BERMAN ENERGY INFRASTRUCTURE AND INCOME FUND ANNOUNCES MONTHLY DISTRIBUTION - Neuberger Berman Energy ( AMEX:NML )

NEW YORK, May 30, 2025 /PRNewswire/ -- Neuberger Berman Energy Infrastructure and Income Fund Inc. ( NYSE:NML ) ( the "Fund" ) has announced a distribution declaration of $0.0584 per share of common stock.

Source: www.benzinga.com
May 30, 2025 | 20:30:00
Category: Markets

Pelican Acquisition Corporation Announces Closing of Full Underwriters' Over-Allotment Option in connection with its Initial Public Offering - Pelican Acquisition ( NASDAQ:PELIU )

NEW YORK, May 30, 2025 ( GLOBE NEWSWIRE ) -- Pelican Acquisition Corporation PELIU the "Company" ) ) announced today that it consummated the sale of an additional 1,125,000 units subject to the underwriters' over-allotment option at a public offering price of $10.00 per unit resulting in gross ...

Source: www.benzinga.com
May 30, 2025 | 20:30:00
Category: News

Publication relating to transparency notifications

Mont-Saint-Guibert ( Belgium ) , May 30, 2025, 10:30 pm CET / 4:30 pm ET - In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) announces that it received a transparency notification as detailed below.

Source: www.globenewswire.com
May 30, 2025 | 20:30:00
Category: News

Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors

SAN DIEGO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Fate Therapeutics, Inc. ( NASDAQ: FATE ) , a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell ( iPSC ) -derived off-the-shelf cellular immunotherapies to patients, today announced the ...

Source: www.globenewswire.com
May 30, 2025 | 20:30:00
Category: News

Publication relating to transparency notifications - Nyxoah ( NASDAQ:NYXH )

Mont-Saint-Guibert ( Belgium ) , May 30, 2025, 10:30 pm CET / 4:30 pm ET - In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA ( Euronext Brussels/Nasdaq: NYXH ) announces that it received a transparency notification as detailed below.

Source: www.benzinga.com
May 30, 2025 | 20:30:00
Category: News

Marijuana Stock Movers For May 30, 2025 - CLS Holdings USA ( OTC:CLSH ) , Canopy Gwth ( NASDAQ:CGC )

CordovaCann LVRLF shares closed up 22.08% at $0.06 Nextleaf Solutions OILFF shares closed up 19.73% at $0.04 Leafbuyer Techs LBUY shares closed up 13.64% at $0.03 Zoned Properties ZDPY shares closed up 9.67% at $0.48 CLS Holdings USA CLSH shares closed up 6.06% at $0.04

Source: www.benzinga.com
May 30, 2025 | 20:30:08
Category: Markets

Fate Therapeutics Appoints Matthew Abernethy, M.B.A., to its Board of Directors - Neurocrine Biosciences ( NASDAQ:NBIX ) , Fate Therapeutics ( NASDAQ:FATE )

SAN DIEGO, May 30, 2025 ( GLOBE NEWSWIRE ) -- Fate Therapeutics, Inc. FATE, a clinical-stage biopharmaceutical company dedicated to bringing a pipeline of induced pluripotent stem cell ( iPSC ) -derived off-the-shelf cellular immunotherapies to patients, today announced the appointment of Matthew ...

Source: www.benzinga.com
May 30, 2025 | 20:30:14
Category: News

© Natavest 2025 - 2026